LSD1-targeted therapy—a multi-purpose key to unlock immunotherapy in small cell lung cancer

por Sattler, Martin, Salgia, Ravi
Publicado 2023

EGFR-Targeted Therapeutics: Focus on SCCHN and NSCLC

por Sattler, Martin, Abidoye, Oyewale, Salgia, Ravi
Publicado 2008

Chimeric Antigen Receptor T Cell Therapy in Acute Myeloid Leukemia: Trials and Tribulations

por Garg, Swati, Ni, Wei, Griffin, James D., Sattler, Martin
Publicado 2023

Novel Therapeutic Targets and Immune Dysfunction in Malignant Pleural Mesothelioma

por Lapidot, Moshe, Saladi, Srinivas Vinod, Salgia, Ravi, Sattler, Martin
Publicado 2022

Spotlight on midostaurin in the treatment of FLT3-mutated acute myeloid leukemia and systemic mastocytosis: design, development, and potential place in therapy

por Weisberg, Ellen, Sattler, Martin, Manley, Paul W, Griffin, James D
Publicado 2017

The improbable targeted therapy: KRAS as an emerging target in non-small cell lung cancer (NSCLC)

por Salgia, Ravi, Pharaon, Rebecca, Mambetsariev, Isa, Nam, Arin, Sattler, Martin
Publicado 2021

NADPH oxidases regulate cell growth and migration in myeloid cells transformed by oncogenic tyrosine kinases

por Reddy, Mamatha M., Fernandes, Margret S., Salgia, Ravi, Levine, Ross L., Griffin, James D., Sattler, Martin
Publicado 2010

Fragmentation of the mitochondrial network in skin in vivo

por Mellem, Daniel, Sattler, Martin, Pagel-Wolff, Sonja, Jaspers, Sören, Wenck, Horst, Rübhausen, Michael Alexander, Fischer, Frank
Publicado 2017

Modeling small cell lung cancer (SCLC) biology through deterministic and stochastic mathematical models

por Salgia, Ravi, Mambetsariev, Isa, Hewelt, Blake, Achuthan, Srisairam, Li, Haiqing, Poroyko, Valeriy, Wang, Yingyu, Sattler, Martin
Publicado 2018

Aconitase Regulation of Erythropoiesis Correlates with a Novel Licensing Function in Erythropoietin-Induced ERK Signaling

por Talbot, Anne-Laure, Bullock, Grant C., Delehanty, Lorrie L., Sattler, Martin, Zhao, Zhizhuang Joe, Goldfarb, Adam N.
Publicado 2011

Kinase domain mutations confer resistance to novel inhibitors targeting JAK2V617F in myeloproliferative neoplasms

por Deshpande, Anagha, Reddy, Mamatha M., Schade, Georg O.M., Ray, Arghya, Chowdary, Tirumala K., Griffin, James D., Sattler, Martin
Publicado 2011

Biomechanical Performance of BoneHelix(®) Compared with Elastic Stable Intramedullary Nailing (ESIN) in a Pediatric Tibia Fracture Model

por Brandes, Laura Leonie, Nicolini, Luis Fernando, Greven, Johannes, Lichte, Philipp, Stopinski, Thomas Thaddäus, Sattler, Martin, Hildebrand, Frank, Pishnamaz, Miguel
Publicado 2021

Inhibition of SDF-1-induced migration of oncogene-driven myeloid leukemia by the L-RNA aptamer (Spiegelmer), NOX-A12, and potentiation of tyrosine kinase inhibition

por Weisberg, Ellen L., Sattler, Martin, Azab, Abdel Kareem, Eulberg, Dirk, Kruschinski, Anna, Manley, Paul W., Stone, Richard, Griffin, James D.
Publicado 2017

Mutant Cbl proteins as oncogenic drivers in myeloproliferative disorders

por Naramura, Mayumi, Nadeau, Scott, Mohapatra, Bhopal, Ahmad, Gulzar, Mukhopadhyay, Chandrani, Sattler, Martin, Raja, Srikumar M, Natarajan, Amarnath, Band, Vimla, Band, Hamid
Publicado 2011

Reversible Resistance Induced by FLT3 Inhibition: A Novel Resistance Mechanism in Mutant FLT3-Expressing Cells

por Weisberg, Ellen, Ray, Arghya, Nelson, Erik, Adamia, Sophia, Barrett, Rosemary, Sattler, Martin, Zhang, Chengsheng, Daley, John F., Frank, David, Fox, Edward, Griffin, James D.
Publicado 2011

Acute myeloid leukemia cells require 6-phosphogluconate dehydrogenase for cell growth and NADPH-dependent metabolic reprogramming

por Bhanot, Haymanti, Weisberg, Ellen L., Reddy, Mamatha M., Nonami, Atsushi, Neuberg, Donna, Stone, Richard M., Podar, Klaus, Salgia, Ravi, Griffin, James D., Sattler, Martin
Publicado 2017

A Closer Look at EGFR Inhibitor Resistance in Non-Small Cell Lung Cancer through the Lens of Precision Medicine

por Sattler, Martin, Mambetsariev, Isa, Fricke, Jeremy, Tan, Tingting, Liu, Sariah, Vaidehi, Nagarajan, Pisick, Evan, Mirzapoiazova, Tamara, Rock, Adam G., Merla, Amartej, Sharma, Sunil, Salgia, Ravi
Publicado 2023

Repurposing of Kinase Inhibitors for Treatment of COVID-19

por Weisberg, Ellen, Parent, Alexander, Yang, Priscilla L., Sattler, Martin, Liu, Qingsong, Liu, Qingwang, Wang, Jinhua, Meng, Chengcheng, Buhrlage, Sara J., Gray, Nathanael, Griffin, James D.
Publicado 2020

The JAK2V617F oncogene requires expression of inducible phosphofructokinase/fructose-bisphosphatase 3 for cell growth and increased metabolic activity

por Reddy, Mamatha M., Fernandes, Margret S., Deshpande, Anagha, Weisberg, Ellen, Inguilizian, Haig V., Abdel-Wahab, Omar, Kung, Andrew L., Levine, Ross L., Griffin, James D., Sattler, Martin
Publicado 2011

Inhibition of the deubiquitinase USP10 induces degradation of SYK

por Yang, Jing, Meng, Chengcheng, Weisberg, Ellen, Case, Abigail, Lamberto, Ilaria, Magin, Robert S., Adamia, Sophia, Wang, Jinhua, Gray, Nathanael, Liu, Suiyang, Stone, Richard, Sattler, Martin, Buhrlage, Sara, Griffin, James D.
Publicado 2020